Collaboration, Licensing and Other Arrangements - Schedule of Revenue from Collaborations and Services (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total revenue from collaborations and services	$ 48,611	$ 18,894	$ 89,237	$ 30,886
Collaborations and services
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total revenue from collaborations and services	11,211	5,868	22,597	8,034
Collaborations and services | License and Distribution Agreement | Cipla Ltd
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total revenue from collaborations and services	36	36	73	73
Collaborations and services | Co-Promotion Agreement | Vertice Pharma
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total revenue from collaborations and services		325		325
Collaborations and services | Other
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total revenue from collaborations and services		114		201
Collaborations and services | United Therapeutics Corporation | Commercial Supply Agreement
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total revenue from collaborations and services	10,933	4,695	22,097	5,879
Collaborations and services | United Therapeutics Corporation | License Agreement
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Total revenue from collaborations and services	$ 242	$ 698	$ 427	$ 1,556